Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
about
Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?
@en
Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?
@nl
type
label
Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?
@en
Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?
@nl
prefLabel
Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?
@en
Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?
@nl
P2093
P2860
P356
P1476
Bax, Bcl-2, and Bax/Bcl-2 as p ...... dy for Bcl-2-directed therapy?
@en
P2093
Bibi Kulsoom
Nasir Ali Afsar
Nikhat Ahmed
Syed Nazrul Hasnain
Zahida Memon
P2860
P304
P356
10.2147/CMAR.S154608
P407
P50
P577
2018-03-02T00:00:00Z